ADNRX | PMAQX | ADNRX / PMAQX | |
Total Expense Ratio | 1.00 | 0.59 | 169% |
Annual Report Gross Expense Ratio | 1.13 | 0.59 | 192% |
Fund Existence | 5 years | 9 years | - |
Gain YTD | 34.317 | 8.156 | 421% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 214M | 33B | 1% |
Annual Yield % from dividends | 0.00 | 0.18 | - |
Returns for 1 year | 82.88 | 11.62 | 713% |
Returns for 3 years | 60.09 | 42.63 | 141% |
Returns for 5 years | N/A | 51.98 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MRSIX | 27.26 | 0.29 | +1.08% |
MFS Research International I | |||
GSCZX | 18.36 | 0.03 | +0.16% |
GuideStone Funds Small Cap Equity Inv | |||
MVGKX | 18.60 | 0.02 | +0.11% |
MFS Low Volatility Global Equity R2 | |||
TIRHX | 18.10 | -0.10 | -0.55% |
Nuveen Real Estate Sec Sel I | |||
GRESX | 11.39 | -0.07 | -0.61% |
Goldman Sachs Real Estate Securities Svc |